(Allergan plc)

	AGN latest price $315.5893 (6.09%) ($312.7131 - $322.7315) on Mon. Jul. 27, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.46% (three month average)
RSI	66
Latest Price	$315.5893(6.09%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.6% a day on average for past five trading days.
Weekly Trend	AGN advances 1.2% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(54%)    IBB(53%)    XBI(47%)    SPY(42%)    IVE(41%)
Factors Impacting AGN price	AGN will decline at least -0.73% in a week (0% probabilities).   VIXM(-31%)    TLT(-18%)    UUP(-6%)    SHY(-6%)    IGOV(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.73% (StdDev 1.46%)
Hourly BBV	0 ()
Intraday Trend	-1.2%

5 Day Moving Average	$305.47(3.31%)
10 Day Moving Average	$306.4(3%)
20 Day Moving Average	$301.47(4.68%)
To recent high	0%
To recent low	15.6%
Market Cap	$104.05b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed